-
ANH News Beat (week 40/2023)
04 October 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
FEATURE: Nucleotides – the next frontier for anti-ageing?
16 August 2023
Emerging science is revealing the crucial role played by nucleotides in slowing the ageing process through their action on telomeres.
-
FEATURE: The cancer breakthroughs most never get to hear about
26 October 2023
An all-star cast of integrative cancer clinicians came together for the Beljanski Integrative Cancer Conference in Jacksonville, Florida, to share their life saving knowledge and findings, while ANH-USA receives award
-
EU continues to tighten noose on vitamin and mineral limits
12 June 2023
European regulator, EFSA, continues its assault on individual nutrient tolerable upper limits, ANH responds to its latest consultation on vitamin D to protect consumer freedom of choice
-
Stomach on fire? Living on PPIs or antacids?
21 June 2023
It might not be because you have too much stomach acid... Find out why controlling heartburn and acid reflux with drugs may be putting your health at risk - and what you can do about it
News / Food4Health Campaign / Food / Health / Campaigns
-
What's driving turbo cancers and autoimmune flare-ups?
23 August 2023
Vaccinologist Geert Vanden Bossche DVM PhD explains the possible mechanism for the widely reported spikes in aggressive cancers and autoimmune flares. Introduced by Rob Verkerk PhD
-
OPINION: Cancer as a survival and healing mechanism
27 July 2023
Medical researcher, Rachel Nicoll PhD, offers an additional perspective on the development and prevention of cancer following the publication of Mark Lintern's new theory
-
ANH News Beat (week 25/2023)
21 June 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
Are you up for taking Big Pharma's new 'skinny' jab?
16 March 2023
After a succession of Big Pharma failures for anti-obesity drugs, will Novo Nordisk's latest offering, that emerges from something of a dark cloud, be just another side effect ladened sticking plaster, or a boon for users and a cash cow for its manufacturer?